Bausch Health falls on phase 3 failure of liver disease complications drug
Source: SeekingAlpha
2026-01-23 08:55:07 ET
More on Bausch Health Companies
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript
- Bausch Health sets 2025 outlook at the higher end of the prior range
- Carl Icahn's top Q3 moves include new stake in EchoStar, exiting Bausch Health
Read the full article on Seeking Alpha
For further details see:
Bausch Health falls on phase 3 failure of liver disease complications drug
Simpson Manufacturing Company Inc.
NASDAQ: SSD
SSD Trading
-2.18% G/L:
$181.63 Last:
100,374 Volume:
$183 Open:
SSD Latest News
February 09, 2026 04:15:00 pm
SIMPSON MANUFACTURING CO., INC. ANNOUNCES 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS; PROVIDES 2026 OUTLOOK
